🔎 Trials Near Me

Utama › Leukemia Mieloid Kronik › Washington › Seattle

Kajian klinikal Leukemia Mieloid Kronik di Seattle, WA

11 kajian untuk Leukemia Mieloid Kronik sedang mencari peserta di lokasi dalam dan sekitar Seattle (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • dan 1 lagi
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Study of Olverembatinib (HQP1351) in Patients With CML-CP

Mengambil pesertaFasa 3
  • Ascentage Investigative Site #1806, Seattle
  • Ascentage Investigative Site #1510, Seattle
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06423911

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

Mengambil pesertaFasa 2
  • Seattle Childrens Hospital, Seattle
Umur 1 hingga 18 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07354074

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Mengambil pesertaFasa 2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
6 Months – 65 Years · Semua jantina · Dikemas kini 22 Jul 2026 · NCT06013423

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Mengambil pesertaKajian pemerhatian
  • Fred Hutchinson Cancer Research Center, Seattle
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
6 Months · Semua jantina · Dikemas kini 29 Mei 2026 · NCT04195633

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Mengambil pesertaFasa 1
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Sehingga umur 80 · Semua jantina · Dikemas kini 18 Mei 2026 · NCT03326921

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

Mengambil pesertaFasa 1/2
  • Fred Hutchinson Cancer Center, Seattle
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Jan 2026 · NCT06163430

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Mengambil pesertaFasa 1
  • Fred Hutchinson Cancer Research Center, Seattle
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Nov 2025 · NCT04260022

TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia

Mengambil pesertaFasa 1
  • Fred Hutchinson Cancer Center, Seattle
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Feb 2025 · NCT06088888

Kajian Leukemia Mieloid Kronik di bandar lain

Kajian lain di Seattle

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.